Free Trial

Bone Biologics (BBLG) News Today

Bone Biologics logo
$1.26 -0.06 (-4.55%)
(As of 11/20/2024 ET)
Bone Biologics Announces Pricing Of $2 Mln Public Offering
Bone Biologics Authorised For 1-for-8 Reverse Stock Split
Bone Biologics Announces 1-for-8 Reverse Stock Split
BBLG Offers Good Entry Opportunity
What Are Biologics?
Bone Biologics Corp BBLG
Bone broth
BBLG Advances Crucial Technology and Solidifies Funding
BBLG - Bone Biologics Corporation
Bone Biologics Effects 1-for-30 Reverse Stock Split
BBLG: BBLG Has Solid Cash and Is Advancing Testing
S-1: Bone Biologics Corp
Get Bone Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter.

Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 

BBLG Media Mentions By Week

BBLG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BBLG
News Sentiment

0.00

0.46

Average
Medical
News Sentiment

BBLG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BBLG Articles
This Week

0

0

BBLG Articles
Average Week

Get Bone Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (OTC:BBLG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners